关注
Daisuke Yabe
Daisuke Yabe
Professor of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
在 kuhp.kyoto-u.ac.jp 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER
T Yang, PJ Espenshade, ME Wright, D Yabe, Y Gong, R Aebersold, ...
Cell 110 (4), 489-500, 2002
12322002
Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant
C Winkler, W Modi, MW Smith, GW Nelson, X Wu, M Carrington, M Dean, ...
Science 279 (5349), 389-393, 1998
9641998
GIP and GLP‐1, the two incretin hormones: similarities and differences
Y Seino, M Fukushima, D Yabe
Journal of diabetes investigation 1 (1‐2), 8-23, 2010
6792010
Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins
D Yabe, MS Brown, JL Goldstein
Proceedings of the National Academy of Sciences 99 (20), 12753-12758, 2002
6642002
Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes
A Nohturfft, D Yabe, JL Goldstein, MS Brown, PJ Espenshade
Cell 102 (3), 315-323, 2000
4202000
Insig-dependent ubiquitination and degradation of mammalian 3-hydroxy-3-methylglutaryl-CoA reductase stimulated by sterols and geranylgeraniol
N Sever, BL Song, D Yabe, JL Goldstein, MS Brown, RA DeBose-Boyd
Journal of Biological Chemistry 278 (52), 52479-52490, 2003
3762003
Japanese clinical practice guideline for diabetes 2016
M Haneda, M Noda, H Origasa, H Noto, D Yabe, Y Fujita, A Goto, T Kondo, ...
Diabetology international 9, 1-45, 2018
3572018
Liver-specific mRNA for Insig-2 down-regulated by insulin: implications for fatty acid synthesis
D Yabe, R Komuro, G Liang, JL Goldstein, MS Brown
Proceedings of the National Academy of Sciences 100 (6), 3155-3160, 2003
3572003
Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: incretin actions beyond the pancreas
Y Seino, D Yabe
Journal of diabetes investigation 4 (2), 108-130, 2013
2932013
β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians
D Yabe, Y Seino, M Fukushima, S Seino
Current diabetes reports 15, 1-9, 2015
2852015
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation
D Yabe, Y Seino
Progress in biophysics and molecular biology 107 (2), 248-256, 2011
2642011
DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries
T Nakamura, P Ruiz-Lozano, V Lindner, D Yabe, M Taniwaki, Y Furukawa, ...
Journal of Biological Chemistry 274 (32), 22476-22483, 1999
2431999
Fibulin-4 conducts proper elastogenesis via interaction with cross-linking enzyme lysyl oxidase
M Horiguchi, T Inoue, T Ohbayashi, M Hirai, K Noda, LY Marmorstein, ...
Proceedings of the National Academy of Sciences 106 (45), 19029-19034, 2009
1982009
Inhibition of Notch/RBP-J signaling induces hair cell formation in neonate mouse cochleas
N Yamamoto, K Tanigaki, M Tsuji, D Yabe, J Ito, T Honjo
Journal of molecular medicine 84, 37-45, 2006
1982006
Sterols block binding of COPII proteins to SCAP, thereby controlling SCAP sorting in ER
PJ Espenshade, WP Li, D Yabe
Proceedings of the National Academy of Sciences 99 (18), 11694-11699, 2002
1982002
Incretin‐based drugs for type 2 diabetes: focus on East Asian perspectives
Y Seino, H Kuwata, D Yabe
Journal of diabetes investigation 7, 102-109, 2016
1762016
Notch/Rbp-j signaling prevents premature endocrine and ductal cell differentiation in the pancreas
J Fujikura, K Hosoda, H Iwakura, T Tomita, M Noguchi, H Masuzaki, ...
Cell metabolism 3 (1), 59-65, 2006
1432006
Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus
WD Strain, X Cos, M Hirst, S Vencio, V Mohan, Z Vokó, D Yabe, M Blüher, ...
Diabetes research and clinical practice 105 (3), 302-312, 2014
1352014
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
D Yabe, J Nakamura, H Kaneto, S Deenadayalan, A Navarria, M Gislum, ...
The Lancet Diabetes & Endocrinology 8 (5), 392-406, 2020
1302020
Three mutations in sterol-sensing domain of SCAP block interaction with insig and render SREBP cleavage insensitive to sterols
D Yabe, ZP Xia, CM Adams, RB Rawson
Proceedings of the National Academy of Sciences 99 (26), 16672-16677, 2002
1282002
系统目前无法执行此操作,请稍后再试。
文章 1–20